1. Lamberg SI, Bunn Jr PA. Proceeding of the workshop on cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndromes). Cancer Treat Rep. 1979;63:561–4.
2. Burg G, Kempf W, Cozzio A, Feit J, Willemze RS, Jaffe E, et al. WHO/EORTC classification of cutaneous lymphomas, histological and molecular aspects. J Cutan Pathol. 2005;32(10):647–74.
3. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. ISCL/EORTC Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(6):1713–22.
4. Alibert JLM. Description des maladies de la peau observees a l’hopital St Louis 1991 1806; Barrois L’aine et Fils(1). Paris, France, p. 413–46.
5. Kim YH, Liu HL, Mraz-Gernhard S, Verghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol. 2003;139:857–66.